Graham Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
17,055
-81,631
| -83% | -$1.76M | 0.01% | 885 |
|
|
2025
Q1 | $1.64M | Buy |
98,686
+36,909
| +60% | +$613K | 0.03% | 374 |
|
|
2024
Q4 | $1.13M | Buy |
+61,777
| New | +$1.13M | 0.02% | 429 |
|
|
2024
Q2 | – | Sell |
-23,238
| Closed | -$430K | – | 981 |
|
|
2024
Q1 | $430K | Buy |
23,238
+13,908
| +149% | +$257K | 0.01% | 647 |
|
|
2023
Q4 | $292K | Buy |
+9,330
| New | +$292K | 0.01% | 713 |
|
|
2022
Q2 | – | Sell |
-17,374
| Closed | -$420K | – | 966 |
|
|
2022
Q1 | $420K | Buy |
+17,374
| New | +$420K | 0.01% | 608 |
|